|
|
Modified by Jenna Smith, on May 15th, 2012| Bee Venom Therapy – or “BVT” is the therapeutic application of honeybee venom, through live bee stings, to bring relief and healing for various spinal, neural, joint, or musculo-skeletal ailments.
This treatment is not to be confused with oral products which have a very small therapeutic benefit, but actual venom which can also be administered by injection and homeopathic – with each treatment weaker than the one listed first.
According to Dr. Dietrich Klinghardt, a leading medical doctor on Lyme disease (currently practicing in Washington State), The pain relieving effect of bee venom in the treatment of clinical conditions similar to Lyme disease has been established a long time ago.
Bee venom contains a number of potent peptides which are responsible for its healing effect, in fact recent research proved that one of the peptides in bee venom, melittin, seems to be the hero in this story.
Melittin has a strong inhibitory effect on the Lyme spirochete at very low doses (“Bee Stings as Lyme Inhibitor” by L. L. Lubke and C. F. Garon, J. Clin. Infect. Diseases, July 1997, 25 Suppl. 1, pp. 48-51).
When the spirochete is inhibited it does not multiply and is vulnerable to the host’s own immune system and to medication. (Melittin Effective Against Infections Organism. By Drs. L Lubke & C. Garon)
The anti microbial agent melittin exhibits powerful in vitro inhibitory effects on the Lyme disease spirochete.
Even though Lyme has demonstrated a capacity to resist the in virto effects of powerful eukaryotic and prokaryotic metabolic inhibitors. However, treatment of laboratory cultures on Barbour-Stoenner-Kelly medium with melittin, a 26 amino acid peptide contained in honeybee venom, showed immediate and profound inhibitory effects when they were monitor by dark field microscopy, field emission scanning electron microscopy, and optical density measurements.
Furthermore, at melittin concentrations as low as 100 mcg/ml, virtually all spirochete motility ceased within seconds of inhibitor addition.
Ultra structural examination of these spirochetes by scanning electron microscopy revealed obvious alterations in the surface envelope of the spirochetes.
The extraordinary sensitivity of Lyme to melittin may provide both a research agent useful in the study of selective permeability in microorganisms, and important clues to the development of effective new drugs against Lyme. This abstract appeared in the journal Clinical Infectious Diseases July 1997. The CID home page is: http://www.journals.uchicago.edu/CID/
The dosage and frequency of treatment is determined by the patient’s clinical response. Patients with Babesia or Mycoplasma infections require higher dosages then those with only a Lyme infection.
Dr. Klinghardt also [...]
Modified by Jenna Smith, on May 15th, 2012| Lyme disease is the fastest growing and most prevalent vector-borne disease in North America and Europe and continues to infect people in every country spreading around the world with frightening speed and intensity.
As most people are aware, one of the biggest problems for the doctors trying to stop this epidemic is that there is not currently a 100% accurate diagnostic test available, and due to heated debate regarding the behavior of the bacteria once a human is infected and appropriate treatment, the sick continue to get sicker as the number of new cases climbs each year.
Although there are several notable projects addressing these problems, in Europe, a very unique project is underway that should give everyone hope for better diagnostic resources in the future. HILYSENS, a 2 year R+D project funded by the European Commission’s Seventh Framework Program (FP7) under Research for the Benefit of the SMEs was officially started on November 1st, 2010. The Kick-off Meeting was held in Barcelona on November 8th, hosted by AROMICS at the PCB and has continued to attract grants and donations to this important project.
The aim of HILYSENS is to develop a novel lab-on-chip diagnostic tool to improve clinical diagnostic, disease monitoring and treatment of Lyme Disease by enabling specific and sensitive detection of the human serological response against its causative agent: Borrelia burgdoferi. Lyme Disease is the most common tick-borne infection in Europe with around 85,000 new cases per year and its incidence is increasing due to climate change. Current laboratory diagnostic methods lack sensitivity and specificity to detect early cases as well as late manifestations of the disease such as chronic or autoimmune-related infections. For this reasons, disease incidence is underestimated as many cases go mis- or undiagnosed. Late, delayed, or inadequate treatment can lead to serious symptoms such as neuroborreliosis or arthritis, which can be disabling and difficult to treat.
Most people are unaware that ticks become active at any temperatures above freezing, in fact they have been documented in active form during winter thaws of only several days. These cold days are actually the greatest time of risk. When the female tick lays her eggs in the late fall, she dies leaving three to six thousand of invaders. As soon as they hatch they are called larvae (with 6 legs) and they are hungry immediately looking for blood! At this stage they are smaller than a poppy seed and most unlikely to be seen on the body and after eating may lie dormant for up to a year. They feed a second time as a nymph once they have grown two more legs, and are still just the size of a freckle. The adult female is the tick usually the one large [...]
Modified by Jenna Smith, on May 14th, 2012| This picture (courtesy of “Nature Review”) is worth a thousand words if you are trying to describe the life cycle of a biofilm.
What does a biofilm have to do with Lyme disease?
Towards the end of the documentary “Under Our Skina” there is a brief interview of Dr. Alan MacDonald who is given credit for discovering the role of biofilms in protecting spirochetes from antibiotics and/or organic bactericides. This discovery stimulated a wave of research regarding biofilms and their role in chronic Lyme disease with some exciting progress. At the time of the movie’s production this was cutting edge research.
[...]
Modified by Jenna Smith, on May 11th, 2012| It is time to take their collective heads out of the sand…yes, that’s right; the “play it safe” doctors, the “lets not make any waves” doctors, the “militaristic” and “opinionated” doctors…As I have been predicting, the facts have caught up with those in power, and it will be very interesting to see how they try to ignore the new evidence.
You can bet Dr. S and others will be trying to discredit this study:
[...]
Modified by Jenna Smith, on May 10th, 2012| A new study by Drs. Monica Embers, Stephen Barthold and colleagues has found that the bacteria that cause Lyme disease, Borrelia burgdorferi (Bb) persist in monkeys after antibiotic treatment. It is the latest in a number of studies that have demonstrated persistent infection in animal models despite treatment. The issue of persistent infection in Lyme disease is a highly controversial issue. Probably the most controversial issue actually. The authors conclude that their studies âoffer proof of the principle that intact spirochetes can persist in an incidental host comparable to humans, following antibiotic therapy.â
[...]
Modified by Jenna Smith, on May 10th, 2012| A fellow Lymie recently emailed me with some wonderful news about people recovering from chronic Lyme disease.
People he knew personally who were getting truly miraculous results with Dr, Jernigan’s treatment at the Hansa Center for Healing in Wichita, Kansas.
Who is Dr. Jernigan, and how is he getting results where others seem to fail?
Modified by Jenna Smith, on May 7th, 2012| The bacteria that cause Lyme disease, one of the most important emerging diseases in the United States, appear to hide out in the lymph nodes, triggering a significant immune response, but one that is not strong enough to rout the infection, according to a new report by researchers at the University of California, Davis
Results from this groundbreaking study involving mice may explain why some people experience repeated infections of Lyme disease. The study appears online in the journal Public Library of Science Pathogens.
[...]
Modified by Jenna Smith, on May 3rd, 2012| Recently a friend emailed me the website for Dr. Charles Crist (pictured) that contains a wonderfully concise description of the outstanding symptoms of Lyme.
This is important for several reasons. As the number of Lyme victims rise, the discussion and medical debate becomes louder and filters into hundreds of thousands of living rooms leaving fear and questions behind. Also, due to the complexity of Lyme disease, it is easy for skeptics to roll their eyes and mentally throw the baby out with the bathwater. As this terrifying epidemic continues to spread, we need to be able to fight for our medical rights and insist on the care we need, as well as discuss the disease in a rational manner.
Lyme disease can and will mimic any disease or illness. Most doctors will look for the more accepted explanation of our symptoms; fibromyalgia, MS, ALS, depression, arthritis, neuropathy…rather than risk stepping out of the mainstream (and the censure of their peers) by looking for Lyme. We need to insist. Knowledge is power, and we don’t need to understand the details of the medical terminology (and with Lyme fog that may be impossible anyways.) We just need to understand enough to ensure that our doctors are giving us the correct diagnostic tests, and not ignoring what could be vital diagnostic information.
Another confusing and often insurmountable problem – even for those doctors who are willing to to consider Lyme, is that the longer we have had it, the deeper it has drilled into our brain, ligaments, joints and soft tissue where blood flow is not as strong, and due to the intelligence of the Lyme bacteria, our body begins to accept the invaders and creates fewer and fewer antibodies – which is how they test for Lyme with the western blot – looking for antibodies that are created by our immune system when it senses a Lyme invasion.
This is why after years of suffering, when my body finally collapsed and I could no longer walk or tolerate sound or light of any kind (in addition to many, many other Lyme symptoms) my Igenex western blot was considered negative by the CDC while my husband who took the test only at my insistence had a clearly positive western blot according to the CDC although he had very few symptoms.
For a much more complete symptom list I offer an ebook called “Could I Have Lyme Disease?”AAÂ along with many other ebooks at http://lymediseaseresource.com/Free_Ebooks.html.
Back to Dr. Crist in Columbus, Missouri. Following is what he has written about chronic Lyme disease that I feel is very valuable for everyone, but especially anyone who is interested in understanding why this disease is becoming such a hotly debated [...]
Modified by Jenna Smith, on April 20th, 2012| One of the most devastating aspects of contracting Lyme disease today is the absence of a reliable test to diagnose Lyme and/or many of the co-infections that contribute to unnecessary suffering and mental anguish.
If you are bitten, the current protocol for doctors is to test the blood for antibodies using the ELISA test – which even some of the proponents of this system will admit to an 45%accuracy rate. Then, IF you have a positive ELISA the protocol is to take a Western Blot which is even worse now that the standard has been changed.
[...]
Modified by Jenna Smith, on April 18th, 2012| Chlamydia Pneumoniae, also known as CPN, is a fast emerging Lyme co-infection with very similar symptoms.
In fact for some who remain very sick and have yet to receive a positive Lyme diagnosis, CPN is something that should definitely be tested for.
|
|
